Documenti analoghi

• Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership
  di: Nadine Kronfli, et al.
  Pubblicazione: (2026)
• Questioning methadone split‐dosing for analgesia among hospitalized patients with opioid use disorder
  di: Dale Terasaki, et al.
  Pubblicazione: (2024)
• The association of methadone use with physical function and frailty among persons who inject drugs
  di: Grace L. Kulik, et al.
  Pubblicazione: (2025)
• Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
  di: Nadine Ezard, et al.
  Pubblicazione: (2025)
• Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada
  di: Jenna Langlois, et al.
  Pubblicazione: (2024)